{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:48:24Z","timestamp":1782870504982,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07110-y","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:24:25Z","timestamp":1782869065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review"],"prefix":"10.1007","author":[{"given":"Sarah Ann","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseeb","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lik Hang N","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Dennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaina","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Burback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Greenshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Jetly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney H","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Swainson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vermetten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"1","key":"7110_CR1","doi-asserted-by":"publisher","first-page":"2485513","DOI":"10.1080\/20008066.2025.2485513","volume":"16","author":"G Agin-Liebes","year":"2025","unstructured":"Agin-Liebes G, Zeifman RJ, Mitchell JM (2025) Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder. Eur J Psychotraumatol 16(1):2485513. https:\/\/doi.org\/10.1080\/20008066.2025.2485513","journal-title":"Eur J Psychotraumatol"},{"key":"7110_CR2","doi-asserted-by":"publisher","first-page":"4283427","DOI":"10.1155\/2018\/4283427","volume":"2018","author":"M Arioli","year":"2018","unstructured":"Arioli M, Crespi C, Canessa N (2018) Social Cognition through the Lens of Cognitive and Clinical Neuroscience. BioMed Res Int 2018:4283427. https:\/\/doi.org\/10.1155\/2018\/4283427","journal-title":"BioMed Res Int"},{"key":"7110_CR3","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z (2024) JBI manual for evidence synthesis. JBI. https:\/\/synthesismanual.jbi.global. Accessed 18 Oct 2024","DOI":"10.46658\/JBIMES-24-01"},{"key":"7110_CR4","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","volume":"10","author":"FS Barrett","year":"2020","unstructured":"Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR (2020) Emotions and brain function are altered up to one month after a single high dose of psilocybin. Sci Rep 10:2214. https:\/\/doi.org\/10.1038\/s41598-020-59282-y","journal-title":"Sci Rep"},{"key":"7110_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","volume":"207","author":"G Bedi","year":"2009","unstructured":"Bedi G, Phan KL, Angstadt M, de Wit H (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207:73\u201383. https:\/\/doi.org\/10.1007\/s00213-009-1635-z","journal-title":"Psychopharmacology"},{"key":"7110_CR6","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/s41386-019-0402-z","volume":"44","author":"AK Bershad","year":"2019","unstructured":"Bershad AK, Mayo LM, Van Hedger K, McGlone F, Walker SC, de Wit H (2019) Effects of MDMA on attention to positive social cues and pleasantness of affective touch. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 44:1698\u20131705. https:\/\/doi.org\/10.1038\/s41386-019-0402-z","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"7110_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s44184-023-00053-8","volume":"3","author":"KV Bhatt","year":"2024","unstructured":"Bhatt KV, Weissman CR (2024) The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects. NPJ Ment Health Res 3:7. https:\/\/doi.org\/10.1038\/s44184-023-00053-8","journal-title":"NPJ Ment Health Res"},{"key":"7110_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2015.07.167","volume":"62","author":"OG Bosch","year":"2015","unstructured":"Bosch OG, Eisenegger C, Gertsch J, von Rotz R, Dornbierer D, Gachet MS et al (2015) Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone. Psychoneuroendocrinology 62:1\u201310. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.07.167","journal-title":"Psychoneuroendocrinology"},{"key":"7110_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/fnhum.2013.00413","volume":"7","author":"LJ Byom","year":"2013","unstructured":"Byom LJ, Mutlu B (2013) Theory of mind: mechanisms, methods, and new directions. Front Hum Neurosci 7:413. https:\/\/doi.org\/10.3389\/fnhum.2013.00413","journal-title":"Front Hum Neurosci"},{"issue":"7","key":"7110_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2174\/1570159X19666210101130258","volume":"19","author":"D Chaliha","year":"2021","unstructured":"Chaliha D, Mamo JC, Albrecht M, Lam V, Takechi R, Vaccarezza M (2021) A systematic review of the MDMA model to address social impairment in autism. Curr Neuropharmacol 19(7):1101\u20131154. https:\/\/doi.org\/10.2174\/1570159X19666210101130258","journal-title":"Curr Neuropharmacol"},{"key":"7110_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1037\/int0000239","volume":"31","author":"AA Contractor","year":"2021","unstructured":"Contractor AA, Weiss NH, Shea MT (2021) Processing of Positive Memories Technique (PPMT) for Posttraumatic Stress Disorder: A Primer. J Psychother Integr 31:195\u2013207. https:\/\/doi.org\/10.1037\/int0000239","journal-title":"J Psychother Integr"},{"key":"7110_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bjc.12238","volume":"59","author":"M Couette","year":"2020","unstructured":"Couette M, Mouchabac S, Bourla A, Nuss P, Ferreri F (2020) Social cognition in post-traumatic stress disorder: A systematic review. Br J Clin Psychol 59:117\u2013138. https:\/\/doi.org\/10.1111\/bjc.12238","journal-title":"Br J Clin Psychol"},{"key":"7110_CR13","doi-asserted-by":"publisher","unstructured":"Craske MG, Dour HJ, Treanor M, Meuret AE (2022) Positive affect treatment for depression and anxiety: therapist guide. Oxford University Press. https:\/\/doi.org\/10.1093\/med-psych\/9780197548523.001.0001","DOI":"10.1093\/med-psych\/9780197548523.001.0001"},{"key":"7110_CR14","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","volume":"235","author":"AL Danforth","year":"2018","unstructured":"Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L et al (2018) Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235:3137\u20133148. https:\/\/doi.org\/10.1007\/s00213-018-5010-9","journal-title":"Psychopharmacology"},{"key":"7110_CR15","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1038\/npp.2016.82","volume":"41","author":"PC Dolder","year":"2016","unstructured":"Dolder PC, Schmid Y, M\u00fcller F, Borgwardt S, Liechti ME (2016) LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality. Neuropsychopharmacology 41:2638\u20132646. https:\/\/doi.org\/10.1038\/npp.2016.82","journal-title":"Neuropsychopharmacology"},{"key":"7110_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12888-016-0794-9","volume":"16","author":"G Domes","year":"2016","unstructured":"Domes G, Normann C, Heinrichs M (2016) The effect of oxytocin on attention to angry and happy faces in chronic depression. BMC Psychiatry 16:92. https:\/\/doi.org\/10.1186\/s12888-016-0794-9","journal-title":"BMC Psychiatry"},{"key":"7110_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/JCP.0000000000001428","volume":"41","author":"RG Dos Santos","year":"2021","unstructured":"Dos Santos RG, Os\u00f3rio FDL, Rocha JM, Rossi GN, Bouso JC, Rodrigues LS et al (2021) Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial. J Clin Psychopharmacol 41:540\u2013550. https:\/\/doi.org\/10.1097\/JCP.0000000000001428","journal-title":"J Clin Psychopharmacol"},{"key":"7110_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1007\/s10803-021-05058-w","volume":"52","author":"J Dubreucq","year":"2022","unstructured":"Dubreucq J, Haesebaert F, Plasse J, Dubreucq M, Franck N (2022) A Systematic Review and Meta-analysis of Social Skills Training for Adults with Autism Spectrum Disorder. J Autism Dev Disord 52:1598\u20131609. https:\/\/doi.org\/10.1007\/s10803-021-05058-w","journal-title":"J Autism Dev Disord"},{"key":"7110_CR19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.psychres.2012.06.034","volume":"200","author":"A Ebert","year":"2012","unstructured":"Ebert A, Haussleiter IS, Juckel G, Br\u00fcne M, Roser P (2012) Impaired facial emotion recognition in a ketamine model of psychosis. Psychiatry Res 200:724\u2013727. https:\/\/doi.org\/10.1016\/j.psychres.2012.06.034","journal-title":"Psychiatry Res"},{"key":"7110_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nn.3086","volume":"15","author":"NI Eisenberger","year":"2012","unstructured":"Eisenberger NI, Cole SW (2012) Social neuroscience and health: neurophysiological mechanisms linking social ties with physical health. Nat Neurosci 15:669\u2013674. https:\/\/doi.org\/10.1038\/nn.3086","journal-title":"Nat Neurosci"},{"issue":"5","key":"7110_CR21","doi-asserted-by":"publisher","first-page":"e15223","DOI":"10.7759\/cureus.15223","volume":"13","author":"S Elkattawy","year":"2021","unstructured":"Elkattawy S, Mowafy A, Younes I, Tucktuck M, Agresti J (2021) Methylenedioxymethamphetamine (MDMA)-induced hyponatremia: case report and literature review. Cureus 13(5):e15223. https:\/\/doi.org\/10.7759\/cureus.15223","journal-title":"Cureus"},{"key":"7110_CR22","doi-asserted-by":"publisher","first-page":"102799","DOI":"10.1016\/j.eclinm.2024.102799","volume":"76","author":"D Erritzoe","year":"2024","unstructured":"Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B et al (2024) Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial. EClinicalMedicine 76:102799. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102799","journal-title":"EClinicalMedicine"},{"key":"7110_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ijnp\/pyy041","volume":"21","author":"JR Gilbert","year":"2018","unstructured":"Gilbert JR, Yarrington JS, Wills KE, Nugent AC, Zarate CA Jr (2018) Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling. Int J Neuropsychopharmacol 21:740\u2013747. https:\/\/doi.org\/10.1093\/ijnp\/pyy041","journal-title":"Int J Neuropsychopharmacol"},{"key":"7110_CR24","doi-asserted-by":"publisher","first-page":"673159","DOI":"10.3389\/fpsyt.2021.673159","volume":"12","author":"JR Gilbert","year":"2021","unstructured":"Gilbert JR, Galiano CS, Nugent AC, Zarate CA (2021) Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression. Front Psychiatry 12:673159. https:\/\/doi.org\/10.3389\/fpsyt.2021.673159","journal-title":"Front Psychiatry"},{"key":"7110_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jad.2022.06.025","volume":"312","author":"JR Gilbert","year":"2022","unstructured":"Gilbert JR, Burton CR, Nugent AC, Zarate CA, Ballard ED (2022) Magnetoencephalography biomarkers of suicide attempt history and antidepressant response to ketamine in treatment-resistant major depression. J Affect Disord 312:188\u2013197. https:\/\/doi.org\/10.1016\/j.jad.2022.06.025","journal-title":"J Affect Disord"},{"key":"7110_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/0269881118762073","volume":"32","author":"P Glue","year":"2018","unstructured":"Glue P, Neehoff SM, Medlicott NJ, Gray A, Kibby G, McNaughton N (2018) Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders. J Psychopharmacol 32:663\u2013667. https:\/\/doi.org\/10.1177\/0269881118762073","journal-title":"J Psychopharmacol"},{"key":"7110_CR27","doi-asserted-by":"publisher","first-page":"109422","DOI":"10.1016\/j.neuropharm.2023.109422","volume":"226","author":"JN Johnston","year":"2023","unstructured":"Johnston JN, Kadriu B, Allen J, Gilbert JR, Henter ID, Zarate CA (2023) Ketamine and Serotonergic Psychedelics: An Update on the Mechanisms and Biosignatures Underlying Rapid-Acting Antidepressant Treatment. Neuropharmacology 226:109422. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109422","journal-title":"Neuropharmacology"},{"key":"7110_CR28","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1038\/s41380-024-02875-0","volume":"30","author":"J Jungwirth","year":"2025","unstructured":"Jungwirth J, von Rotz R, Dziobek I, Vollenweider FX, Preller KH (2025) Psilocybin increases emotional empathy in patients with major depression. Mol Psychiatry 30:2665\u20132672. https:\/\/doi.org\/10.1038\/s41380-024-02875-0","journal-title":"Mol Psychiatry"},{"key":"7110_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/psymed.2023.0023","volume":"1","author":"H Kaur","year":"2023","unstructured":"Kaur H, Karabulut S, Gauld JW, Fagot SA, Holloway KN, Shaw HE et al (2023) Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder. Psychedelic Med 1:166\u2013185. https:\/\/doi.org\/10.1089\/psymed.2023.0023","journal-title":"Psychedelic Med"},{"key":"7110_CR30","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00213-014-3752-6","volume":"232","author":"MG Kirkpatrick","year":"2015","unstructured":"Kirkpatrick MG, de Wit H (2015) MDMA: a social drug in a social context. Psychopharmacology 232:1155\u20131163. https:\/\/doi.org\/10.1007\/s00213-014-3752-6","journal-title":"Psychopharmacology"},{"key":"7110_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fpsyt.2019.00347","volume":"10","author":"MJ Knight","year":"2019","unstructured":"Knight MJ, Baune BT (2019) The Direct and Indirect Relationship Between Social Cognition and Psychosocial Dysfunction in Major Depressive Disorder. Front Psychiatry 10:347. https:\/\/doi.org\/10.3389\/fpsyt.2019.00347","journal-title":"Front Psychiatry"},{"key":"7110_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jpsychires.2021.07.029","volume":"142","author":"G Lahera","year":"2021","unstructured":"Lahera G, Reboreda A, Vallesp\u00ed A, Vidal C, L\u00f3pez V, Aznar A et al (2021) Social Cognition and Interaction Training (SCIT) versus Training in Affect Recognition (TAR) in patients with schizophrenia: A randomized controlled trial. J Psychiatr Res 142:101\u2013109. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.07.029","journal-title":"J Psychiatr Res"},{"key":"7110_CR33","doi-asserted-by":"publisher","first-page":"1566811","DOI":"10.3389\/fpsyt.2025.1566811","volume":"16","author":"J Li","year":"2025","unstructured":"Li J, Li R, Li D, Ji SS, Luo X, Zhang Y (2025) Social cognition and interactive training for first-episode, drug-na\u00efve MDD patients. Front Psychiatry 16:1566811. https:\/\/doi.org\/10.3389\/fpsyt.2025.1566811","journal-title":"Front Psychiatry"},{"key":"7110_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.psychres.2012.01.030","volume":"198","author":"FT Maalouf","year":"2012","unstructured":"Maalouf FT, Clark L, Tavitian L, Sahakian BJ, Brent D, Phillips ML (2012) Bias to negative emotions: A depression state-dependent marker in adolescent major depressive disorder. Psychiatry Res 198:28\u201333. https:\/\/doi.org\/10.1016\/j.psychres.2012.01.030","journal-title":"Psychiatry Res"},{"key":"7110_CR35","doi-asserted-by":"publisher","first-page":"1011103","DOI":"10.3389\/fnins.2022.1011103","volume":"16","author":"M Marchi","year":"2022","unstructured":"Marchi M, Magarini FM, Galli G et al (2022) The effect of ketamine on cognition, anxiety, and social functioning in adults with psychiatric disorders: a systematic review and meta-analysis. Front Neurosci 16:1011103. https:\/\/doi.org\/10.3389\/fnins.2022.1011103","journal-title":"Front Neurosci"},{"key":"7110_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/02698811221140011","volume":"37","author":"M Marguilho","year":"2023","unstructured":"Marguilho M, Figueiredo I, Castro-Rodrigues P (2023) A unified model of ketamine\u2019s dissociative and psychedelic properties. J Psychopharmacol 37:14\u201332. https:\/\/doi.org\/10.1177\/02698811221140011","journal-title":"J Psychopharmacol"},{"key":"7110_CR37","doi-asserted-by":"publisher","first-page":"1293243","DOI":"10.3389\/fpsyt.2023.1293243","volume":"14","author":"E Marseille","year":"2023","unstructured":"Marseille E, Stauffer CS, Agrawal M, Thambi P, Roddy K, Mithoefer M et al (2023) Group psychedelic therapy: empirical estimates of cost-savings and improved access. Front Psychiatry 14:1293243. https:\/\/doi.org\/10.3389\/fpsyt.2023.1293243","journal-title":"Front Psychiatry"},{"key":"7110_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/02791072.2019.1580804","volume":"51","author":"NL Mason","year":"2019","unstructured":"Mason NL, Mischler E, Uthaug MV, Kuypers KPC (2019) Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being. J Psychoact Drugs 51:123\u2013134. https:\/\/doi.org\/10.1080\/02791072.2019.1580804","journal-title":"J Psychoact Drugs"},{"key":"7110_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-030-88538-0_5","volume-title":"Handbook of autism and pervasive developmental disorder: assessment, diagnosis, and treatment","author":"KE May","year":"2022","unstructured":"May KE, Martino MA, Kana RK (2022) Emotional cognition, theory of mind, and face recognition in individuals with autism and PDDs. In: Matson JL, Sturmey P (eds) Handbook of autism and pervasive developmental disorder: assessment, diagnosis, and treatment. Springer, Cham, pp 113\u2013133. https:\/\/doi.org\/10.1007\/978-3-030-88538-0_5"},{"key":"7110_CR40","doi-asserted-by":"publisher","first-page":"688439","DOI":"10.3389\/fpsyt.2021.688439","volume":"12","author":"J Mendes Rocha","year":"2021","unstructured":"Mendes Rocha J, Rossi GN, Os\u00f3rio FL, Bouso Saiz JC, Silveira GDO, Yonamine M et al (2021) Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers. Front Psychiatry 12:688439. https:\/\/doi.org\/10.3389\/fpsyt.2021.688439","journal-title":"Front Psychiatry"},{"key":"7110_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/0269881119895520","volume":"34","author":"LJ Mertens","year":"2020","unstructured":"Mertens LJ, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL (2020) Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. J Psychopharmacol 34:167\u2013180. https:\/\/doi.org\/10.1177\/0269881119895520","journal-title":"J Psychopharmacol"},{"key":"7110_CR42","doi-asserted-by":"publisher","first-page":"100171","DOI":"10.1016\/j.scog.2019.100171","volume":"20","author":"K Miley","year":"2019","unstructured":"Miley K, Fisher M, Nahum M, Howard E, Rowlands A, Brandrett B et al (2019) Six month durability of targeted cognitive training supplemented with social cognition exercises in schizophrenia. Schizophr Res Cogn 20:100171. https:\/\/doi.org\/10.1016\/j.scog.2019.100171","journal-title":"Schizophr Res Cogn"},{"key":"7110_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41386-023-01772-4","volume":"49","author":"H Molla","year":"2024","unstructured":"Molla H, Lee R, Tare I, De Wit H (2024) Greater subjective effects of a low dose of LSD in participants with depressed mood. Neuropsychopharmacology 49:774\u2013781. https:\/\/doi.org\/10.1038\/s41386-023-01772-4","journal-title":"Neuropsychopharmacology"},{"key":"7110_CR44","doi-asserted-by":"publisher","first-page":"e509","DOI":"10.1038\/tp.2015.10","volume":"5","author":"JW Murrough","year":"2015","unstructured":"Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ et al (2015) Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. Transl Psychiatry 5:e509\u2013e509. https:\/\/doi.org\/10.1038\/tp.2015.10","journal-title":"Transl Psychiatry"},{"key":"7110_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/B978-0-12-398336-7.00033-4","volume-title":"Principles of addiction: comprehensive addictive behaviors and disorders","author":"C Neighbors","year":"2013","unstructured":"Neighbors C, Foster DW, Fossos N (2013) Peer influences on addiction. In: Miller PM (ed) Principles of addiction: comprehensive addictive behaviors and disorders. Academic, San Diego, pp 323\u2013331. https:\/\/doi.org\/10.1016\/B978-0-12-398336-7.00033-4"},{"key":"7110_CR46","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"7110_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.euroneuro.2014.07.012","volume":"25","author":"MM Perez-Rodriguez","year":"2015","unstructured":"Perez-Rodriguez MM, Mahon K, Russo M, Ungar AK, Burdick KE (2015) Oxytocin and Social Cognition in Affective and Psychotic Disorders. Eur Neuropsychopharmacol 25:265\u2013282. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.07.012","journal-title":"Eur Neuropsychopharmacol"},{"key":"7110_CR48","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3389\/fpsyt.2019.00881","volume":"10","author":"KH Preller","year":"2019","unstructured":"Preller KH, Vollenweider FX (2019) Modulation of social cognition via hallucinogens and entactogens. Front Psychiatry 10:881. https:\/\/doi.org\/10.3389\/fpsyt.2019.00881","journal-title":"Front Psychiatry"},{"key":"7110_CR49","doi-asserted-by":"publisher","first-page":"e48719","DOI":"10.7759\/cureus.48719","volume":"15","author":"P Raj","year":"2023","unstructured":"Raj P, Rauniyar S, Sapkale B (2023) Psychedelic Drugs or Hallucinogens. Exploring Their Med Potential Cureus 15:e48719. https:\/\/doi.org\/10.7759\/cureus.48719","journal-title":"Exploring Their Med Potential Cureus"},{"issue":"5","key":"7110_CR50","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/13803395.2024.2363343","volume":"46","author":"L Ramos","year":"2024","unstructured":"Ramos L, Vicente SG (2024) The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review. J Clin Exp Neuropsychol 46(5):393\u2013421. https:\/\/doi.org\/10.1080\/13803395.2024.2363343","journal-title":"J Clin Exp Neuropsychol"},{"key":"7110_CR51","doi-asserted-by":"publisher","unstructured":"Ratner KG (2020) Social cognition. Oxford Research Encyclopedia of Psychology. Oxford University Press. https:\/\/doi.org\/10.1093\/acrefore\/9780190236557.013.234. Accessed 4 Apr 2025","DOI":"10.1093\/acrefore\/9780190236557.013.234"},{"key":"7110_CR52","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bpsc.2019.01.005","volume":"4","author":"JL Reed","year":"2019","unstructured":"Reed JL, Nugent AC, Furey ML, Szczepanik JE, Evans JW, Zarate CA (2019) Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants. Biol Psychiatry Cogn Neurosci Neuroimaging 4:610\u2013618. https:\/\/doi.org\/10.1016\/j.bpsc.2019.01.005","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"7110_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/15622975.2024.2441304","volume":"26","author":"C Reif-Leonhard","year":"2025","unstructured":"Reif-Leonhard C, Millard SN, Ferdowssian D, Finlayson A, Aichholzer M, Repple J et al (2025) Effects of repeated intravenous esketamine administration on affective biases. World J Biol Psychiatry 26:60\u201373. https:\/\/doi.org\/10.1080\/15622975.2024.2441304","journal-title":"World J Biol Psychiatry"},{"key":"7110_CR54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fnins.2012.00195","volume":"6","author":"S Roepke","year":"2013","unstructured":"Roepke S, Vater A, Prei\u00dfler S, Heekeren HR, Dziobek I (2013) Social cognition in borderline personality disorder. Front Neurosci 6:195. https:\/\/doi.org\/10.3389\/fnins.2012.00195","journal-title":"Front Neurosci"},{"key":"7110_CR55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","volume":"142","author":"L Roseman","year":"2018","unstructured":"Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL (2018) Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology 142:263\u2013269. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.041","journal-title":"Neuropharmacology"},{"key":"7110_CR56","doi-asserted-by":"publisher","first-page":"592937","DOI":"10.3389\/fpsyt.2020.592937","volume":"11","author":"C Samaey","year":"2020","unstructured":"Samaey C, Van der Donck S, van Winkel R, Boets B (2020) Facial Expression Processing Across the Autism\u2013Psychosis Spectra: A Review of Neural Findings and Associations With Adverse Childhood Events. Front Psychiatry 11:592937. https:\/\/doi.org\/10.3389\/fpsyt.2020.592937","journal-title":"Front Psychiatry"},{"key":"7110_CR57","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.bpsc.2024.02.001","volume":"9","author":"Y Schmid","year":"2024","unstructured":"Schmid Y, Bershad AK (2024) Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy. Biol Psychiatry Cogn Neurosci Neuroimaging 9:490\u2013499. https:\/\/doi.org\/10.1016\/j.bpsc.2024.02.001","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"7","key":"7110_CR58","doi-asserted-by":"publisher","first-page":"e0307491","DOI":"10.1371\/journal.pone.0307491","volume":"19","author":"SA Smith","year":"2024","unstructured":"Smith SA, Smith S, Dennett L, Zhang Y (2024) Investigating the impact of psychedelic drugs on social cognition defects: a scoping review protocol. PLoS ONE 19(7):e0307491. https:\/\/doi.org\/10.1371\/journal.pone.0307491","journal-title":"PLoS ONE"},{"key":"7110_CR59","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00213-017-4754-y","volume":"235","author":"JB Stroud","year":"2018","unstructured":"Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ et al (2018) Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology 235:459\u2013466. https:\/\/doi.org\/10.1007\/s00213-017-4754-y","journal-title":"Psychopharmacology"},{"key":"7110_CR60","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/npp.2017.194","volume":"43","author":"JH Taylor","year":"2018","unstructured":"Taylor JH, Landeros-Weisenberger A, Coughlin C, Mulqueen J, Johnson JA, Gabriel D et al (2018) Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial. Neuropsychopharmacology 43:325\u2013333. https:\/\/doi.org\/10.1038\/npp.2017.194","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"7110_CR61","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s10803-008-0545-y","volume":"38","author":"LM Turner-Brown","year":"2008","unstructured":"Turner-Brown LM, Perry TD, Dichter GS, Bodfish JW, Penn DL (2008) Brief report: feasibility of social cognition and interaction training for adults with high functioning autism. J Autism Dev Disord 38(9):1777\u20131784. https:\/\/doi.org\/10.1007\/s10803-008-0545-y","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"7110_CR63","doi-asserted-by":"publisher","first-page":"e0295926","DOI":"10.1371\/journal.pone.0295926","volume":"19","author":"BA van der Kolk","year":"2024","unstructured":"van der Kolk BA, Wang JB, Yehuda R, Bedrosian L, Coker AR, Harrison C, Mithoefer M, Yazar-Klosinski B, Emerson A, Doblin R (2024) Effects of MDMA-assisted therapy for PTSD on self-experience. PLoS ONE 19(1):e0295926. https:\/\/doi.org\/10.1371\/journal.pone.0295926","journal-title":"PLoS ONE"},{"issue":"2","key":"7110_CR62","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11065-024-09643-5","volume":"35","author":"DE Vance","year":"2025","unstructured":"Vance DE, Billings R, Lambert CC, Fazeli PL, Goodin BR, Kempf M-C et al (2025) A Systematic Review and Meta-Analysis of Social Cognition Among People Living with HIV: Implications for Non-Social Cognition and Social Everyday Functioning. Neuropsychol Rev 35(2):381\u2013410. https:\/\/doi.org\/10.1007\/s11065-024-09643-5","journal-title":"Neuropsychol Rev"},{"key":"7110_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.euroneuro.2021.07.005","volume":"53","author":"MJ Voncken","year":"2021","unstructured":"Voncken MJ, Dijk C, St\u00f6hr F, Niesten IJM, Schruers K, Kuypers KPC (2021) The effect of intranasally administered oxytocin on observed social behavior in social anxiety disorder. Eur Neuropsychopharmacol 53:25\u201333. https:\/\/doi.org\/10.1016\/j.euroneuro.2021.07.005","journal-title":"Eur Neuropsychopharmacol"},{"key":"7110_CR65","doi-asserted-by":"publisher","first-page":"702838","DOI":"10.3389\/fpsyt.2021.702838","volume":"12","author":"AC Wagner","year":"2021","unstructured":"Wagner AC, Liebman RE, Mithoefer AT, Mithoefer MC, Monson CM (2021) Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD. Front Psychiatry 12:702838. https:\/\/doi.org\/10.3389\/fpsyt.2021.702838","journal-title":"Front Psychiatry"},{"key":"7110_CR66","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s10803-020-04542-z","volume":"51","author":"LK Wink","year":"2021","unstructured":"Wink LK, Reisinger DL, Horn P, Shaffer RC, O\u2019Brien K, Schmitt L et al (2021) Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder\u2014Initial Results of a Randomized, Controlled, Crossover, Pilot Study. J Autism Dev Disord 51:1392\u20131399. https:\/\/doi.org\/10.1007\/s10803-020-04542-z","journal-title":"J Autism Dev Disord"},{"key":"7110_CR67","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.psychres.2018.11.008","volume":"270","author":"S Zhu","year":"2018","unstructured":"Zhu S, Zhu K, Jiang D, Shi J (2018) Social cognition and interaction training for major depression: A preliminary study. Psychiatry Res 270:890\u2013894. https:\/\/doi.org\/10.1016\/j.psychres.2018.11.008","journal-title":"Psychiatry Res"},{"key":"7110_CR68","doi-asserted-by":"publisher","unstructured":"Lundin NB, Sepe-Forrest L, Gilbert JR, Carver FW, Furey ML, Zarate CA Jr, et al (2021) Ketamine alters electrophysiological responses to emotional faces in Major Depressive Disorder. J Affect Disord 279:239\u2013249. https:\/\/doi.org\/10.1016\/j.jad.2020.10.007","DOI":"10.1016\/j.jad.2020.10.007"},{"key":"7110_CR69","doi-asserted-by":"publisher","unstructured":"Mazza M, Tempesta D, Pino MC, Nigri A, Catalucci A, Guadagni V, et al (2015) Neural activity related to cognitive and emotional empathy in post-traumatic stress disorder. Behav Brain Res 282:37\u201345. https:\/\/doi.org\/10.1016\/j.bbr.2014.12.049","DOI":"10.1016\/j.bbr.2014.12.049"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07110-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:24:32Z","timestamp":1782869072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":69,"alternative-id":["7110"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07110-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate declarations"}},{"value":"Jennifer Swainson receives funding and has memberships at Abbvie, Bausch, Eisai, Idorsia, Janssen, Otsuka, Lundbeck and CIHR. Lisa Burback receives funding from the Canadian Institutes of Health Research. Rakesh Jetly receives funding from the Canadian Institutes of Health Research and has a relationship with Guardians Mental Health Research Institute. Venkat Bhat is supported by an Academic Scholar Award from the University of Toronto Department of Psychiatry and has received research support from the Canadian Institutes of Health Research, Brain & Behavior Foundation, Ontario Ministry of Health Innovation Funds, Royal College of Physicians and Surgeons of Canada, Department of National Defense (Government of Canada), New Frontiers in Research Fund, Associated Medical Services Inc. Healthcare, American Foundation for Suicide Prevention, Roche Canada, Novartis, and Eisai. Eric Vemetten receives funding from Trauma Innovation Network. Sidney Kennedy has received funding for consulting or speaking engagements from Boehringer-Ingelheim, Brain Canada, Janssen, Lundbeck, Otsuka, Servier. Sidney Kennedy has also received research support from Brain Canada, the Canadian Institutes of Health Research, Janssen, Lundbeck, Neurocrine, Ontario Brain Institute, Otsuka. Sidney Kennedy has led contracted research for COMPASS, Denovo, Janssen. Yanbo Zhang receives funding from the Canadian Institutes of Health Research. Sarah Ann Smith, Haseeb Mohammed, Lik Hang N Lee, Liz Dennett, Shaina Smith, Olga Winkler, Andrew Greenshaw, Bo Cao, Xin-Min Li declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}